Financhill
Sell
34

IRLCF Quote, Financials, Valuation and Earnings

Last price:
$275.00
Seasonality move :
-29.07%
Day range:
$275.00 - $275.00
52-week range:
$219.00 - $578.00
Dividend yield:
0.73%
P/E ratio:
12.70x
P/S ratio:
0.30x
P/B ratio:
0.72x
Volume:
--
Avg. volume:
--
1-year change:
22.41%
Market cap:
$2.1B
Revenue:
$6.8B
EPS (TTM):
$21.65
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $5B $7B $10B $7.5B $6.8B
Revenue Growth (YoY) -4.33% 37.91% 44% -24.75% -9.22%
 
Cost of Revenues $3.6B $4.3B $5B $4.9B $4.6B
Gross Profit $1.5B $2.6B $5B $2.7B $2.3B
Gross Profit Margin 29.45% 37.47% 50.2% 35.39% 32.92%
 
R&D Expenses $54M $64M $68M $71M $69M
Selling, General & Admin $731M $1B $1.1B $1B $1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.2B $1.4B $1.6B $1.5B $1.5B
Operating Income $265M $1.2B $3.5B $1.2B $765M
 
Net Interest Expenses $192M $183M $119M $113M $108M
EBT. Incl. Unusual Items -$34M $1B $3.3B $962M $631M
Earnings of Discontinued Ops. -$97M -$181M $50M -- --
Income Tax Expense $25M $260M $1.2B $287M $157M
Net Income to Company -$156M $562M $2.2B $675M $474M
 
Minority Interest in Earnings -$17M -$474M -$1.3B -$402M -$284M
Net Income to Common Excl Extra Items -$173M $88M $953M $273M $190M
 
Basic EPS (Cont. Ops) -$22.69 $11.54 $124.96 $35.80 $25.30
Diluted EPS (Cont. Ops) -$22.69 $11.53 $124.93 $35.79 $25.30
Weighted Average Basic Share $7.6M $7.6M $7.6M $7.6M $7.5M
Weighted Average Diluted Share $7.6M $7.6M $7.6M $7.6M $7.5M
 
EBITDA $711M $1.9B $4.1B $1.7B $1.4B
EBIT $127M $1.2B $3.5B $1.2B $813M
 
Revenue (Reported) $5B $7B $10B $7.5B $6.8B
Operating Income (Reported) $265M $1.2B $3.5B $1.2B $765M
Operating Income (Adjusted) $127M $1.2B $3.5B $1.2B $813M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.5B $2.5B $2.1B $1.7B $1.8B
Revenue Growth (YoY) 14.48% 67.22% -16.2% -18.01% 1.84%
 
Cost of Revenues $1B $1.3B $1.3B $1.2B $1.2B
Gross Profit $494M $1.2B $845M $556M $559M
Gross Profit Margin 32.72% 49.27% 39.93% 32.05% 31.64%
 
R&D Expenses $15M $18M $18M $17M $18M
Selling, General & Admin $293M $351M $335M $339M $348M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $308M $369M $353M $356M $366M
Operating Income $186M $875M $492M $200M $193M
 
Net Interest Expenses $40M $66M $46M $34M $39M
EBT. Incl. Unusual Items $158M $833M $415M $166M $142M
Earnings of Discontinued Ops. -- $39M -- -- --
Income Tax Expense $23M $181M $127M $26M $40M
Net Income to Company $135M $691M $288M $140M $102M
 
Minority Interest in Earnings -$80M -$371M -$171M -$78M -$67M
Net Income to Common Excl Extra Items $55M $320M $117M $62M $35M
 
Basic EPS (Cont. Ops) $7.21 $41.96 $15.33 $8.22 $4.67
Diluted EPS (Cont. Ops) $7.21 $41.93 $15.33 $8.22 $4.67
Weighted Average Basic Share $7.6M $7.6M $7.6M $7.5M $7.5M
Weighted Average Diluted Share $7.6M $7.6M $7.6M $7.5M $7.5M
 
EBITDA $381M $1.1B $662M $392M $376M
EBIT $263M $944M $531M $244M $224M
 
Revenue (Reported) $1.5B $2.5B $2.1B $1.7B $1.8B
Operating Income (Reported) $186M $875M $492M $200M $193M
Operating Income (Adjusted) $263M $944M $531M $244M $224M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $5.2B $8B $9.6B $7.2B $6.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.7B $4.6B $5B $4.8B $4.6B
Gross Profit $1.6B $3.4B $4.6B $2.4B $2.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $55M $67M $68M $70M $70M
Selling, General & Admin $770M $1.1B $1.1B $1B $1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.3B $1.5B $1.5B $1.5B $1.5B
Operating Income $320M $1.9B $3.1B $894M $758M
 
Net Interest Expenses $163M $209M $99M $101M $113M
EBT. Incl. Unusual Items $112M $1.7B $2.9B $713M $607M
Earnings of Discontinued Ops. -- -$179M $11M -- --
Income Tax Expense $27M $418M $1.1B $186M $171M
Net Income to Company -$12M $1.1B $1.8B $527M $436M
 
Minority Interest in Earnings -$64M -$765M -$1.1B -$309M -$273M
Net Income to Common Excl Extra Items -$76M $353M $750M $218M $163M
 
Basic EPS (Cont. Ops) -$9.36 $46.28 $98.33 $28.68 $21.65
Diluted EPS (Cont. Ops) -$9.36 $46.24 $98.28 $28.68 $21.65
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $909M $2.7B $3.7B $1.4B $1.4B
EBIT $326M $2B $3.1B $878M $793M
 
Revenue (Reported) $5.2B $8B $9.6B $7.2B $6.9B
Operating Income (Reported) $320M $1.9B $3.1B $894M $758M
Operating Income (Adjusted) $326M $2B $3.1B $878M $793M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.5B $2.5B $2.1B $1.7B $1.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1B $1.3B $1.3B $1.2B $1.2B
Gross Profit $494M $1.2B $845M $556M $559M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $15M $18M $18M $17M $18M
Selling, General & Admin $293M $351M $335M $339M $348M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $308M $369M $353M $356M $366M
Operating Income $186M $875M $492M $200M $193M
 
Net Interest Expenses $40M $66M $46M $34M $39M
EBT. Incl. Unusual Items $158M $833M $415M $166M $142M
Earnings of Discontinued Ops. -- $39M -- -- --
Income Tax Expense $23M $181M $127M $26M $40M
Net Income to Company $135M $691M $288M $140M $102M
 
Minority Interest in Earnings -$80M -$371M -$171M -$78M -$67M
Net Income to Common Excl Extra Items $55M $320M $117M $62M $35M
 
Basic EPS (Cont. Ops) $7.21 $41.96 $15.33 $8.22 $4.67
Diluted EPS (Cont. Ops) $7.21 $41.93 $15.33 $8.22 $4.67
Weighted Average Basic Share $7.6M $7.6M $7.6M $7.5M $7.5M
Weighted Average Diluted Share $7.6M $7.6M $7.6M $7.5M $7.5M
 
EBITDA $381M $1.1B $662M $392M $376M
EBIT $263M $944M $531M $244M $224M
 
Revenue (Reported) $1.5B $2.5B $2.1B $1.7B $1.8B
Operating Income (Reported) $186M $875M $492M $200M $193M
Operating Income (Adjusted) $263M $944M $531M $244M $224M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $618M $508M $762M $537M $618M
Short Term Investments $438M $630M $810M $1B $706M
Accounts Receivable, Net $883M $1.4B $1.6B $1.4B $1.3B
Inventory $1.3B $1.6B $2.1B $1.7B $1.6B
Prepaid Expenses $50M $51M $70M $35M $41M
Other Current Assets -- -- -- -- --
Total Current Assets $3.5B $4.5B $5.6B $5B $4.5B
 
Property Plant And Equipment $5.6B $5.8B $6B $6.4B $6.5B
Long-Term Investments -- -- -- -- --
Goodwill $501M $683M $688M $711M $724M
Other Intangibles $364M $378M $357M $354M $335M
Other Long-Term Assets $162M $170M $82M $104M $110M
Total Assets $11.1B $12.3B $13.1B $12.9B $12.5B
 
Accounts Payable $740M $1.1B $1B $912M $1B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $64M $63M $68M $72M $78M
Other Current Liabilities $160M $204M $281M $192M $189M
Total Current Liabilities $2.5B $2.9B $2.9B $2.9B $2.6B
 
Long-Term Debt $3.2B -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $7.3B $8B $7.2B $6.5B $6.1B
 
Common Stock $326M $326M $326M $326M $326M
Other Common Equity Adj -- -- -- -- --
Common Equity $1.4B $1.5B $2.5B $2.8B $2.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.4B $2.7B $3.4B $3.6B $3.6B
Total Equity $3.8B $4.3B $5.9B $6.4B $6.4B
 
Total Liabilities and Equity $11.1B $12.3B $13.1B $12.9B $12.5B
Cash and Short Terms $1.1B $1.1B $1.6B $1.6B $1.3B
Total Debt $4.1B $4.5B $3.9B $3.5B $2.9B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $244M $842M $673M $550M $417M
Short Term Investments $463M $561M $1B $912M $797M
Accounts Receivable, Net $1.1B $1.9B $1.6B $1.5B $1.5B
Inventory $1.2B $1.7B $2.1B $1.6B $1.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $3.4B $5.3B $5.8B $4.9B $4.6B
 
Property Plant And Equipment $5.6B $5.8B $6.1B $6.3B $6.6B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $264M $319M $210M $242M $266M
Total Assets $10.9B $13.2B $13.3B $12.8B $12.9B
 
Accounts Payable $752M $1.1B $967M $914M $1B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $754M $1.1B $1B $866M $959M
Total Current Liabilities $2.3B $3B $3B $2.7B $2.9B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $7.1B $8B $7.2B $6.4B $6.4B
 
Common Stock $326M $326M $326M $326M $326M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.4B $3.2B $3.5B $3.6B $3.6B
Total Equity $3.9B $5.2B $6.1B $6.4B $6.5B
 
Total Liabilities and Equity $10.9B $13.2B $13.3B $12.8B $12.9B
Cash and Short Terms $707M $1.4B $1.7B $1.5B $1.2B
Total Debt $4.2B $4.5B $4B $3.4B $3.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$156M $562M $2.2B $675M $474M
Depreciation & Amoritzation $584M $750M $539M $540M $614M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$82M -$417M -$262M $278M $65M
Change in Inventories $54M -$267M -$527M $465M -$7M
Cash From Operations $917M $1.1B $2.2B $1.8B $1.4B
 
Capital Expenditures $627M $611M $747M $780M $713M
Cash Acquisitions -$1M -$326M $15M $6M -$55M
Cash From Investing -$398M -$830M -$748M -$1.1B -$343M
 
Dividends Paid (Ex Special Dividend) -- -- -$78M -- -$37M
Special Dividend Paid
Long-Term Debt Issued $1.5B $1.5B $1.1B $633M $889M
Long-Term Debt Repaid -$1.4B -$1.5B -$1.6B -$1.1B -$1.4B
Repurchase of Common Stock -- -- -- -$13M -$20M
Other Financing Activities $12M $18M $241M -$8M -$12M
Cash From Financing -$192M -$403M -$1.2B -$931M -$979M
 
Beginning Cash (CF) $274M $618M $508M $762M $537M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $327M -$125M $300M -$205M $101M
Ending Cash (CF) $618M $508M $762M $537M $618M
 
Levered Free Cash Flow $290M $497M $1.5B $1B $710M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $135M $691M $288M $140M $102M
Depreciation & Amoritzation $118M $123M $131M $148M $152M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$156M -$470M -$41M -$123M -$217M
Change in Inventories $30M -$87M $51M $51M $28M
Cash From Operations $224M $358M $432M $275M $155M
 
Capital Expenditures $147M $131M $164M $145M $190M
Cash Acquisitions -$64M $20M $2M -$7M -$119M
Cash From Investing -$336M -$53M -$435M -$3M -$381M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $310M $393M $258M $198M $361M
Long-Term Debt Repaid -$496M -$386M -$255M -$386M -$397M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $16M $237M $7M -- -$2M
Cash From Financing -$263M $23M -$87M -$254M $18M
 
Beginning Cash (CF) $618M $508M $762M $537M $618M
Foreign Exchange Rate Adjustment $1M $6M $1M -$5M $7M
Additions / Reductions -$375M $328M -$90M $18M -$208M
Ending Cash (CF) $244M $842M $673M $550M $417M
 
Levered Free Cash Flow $77M $227M $268M $130M -$35M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$12M $1.1B $1.8B $527M $436M
Depreciation & Amoritzation $583M $755M $547M $557M $618M
Stock-Based Compensation -$3M -- -- -- --
Change in Accounts Receivable -$46M -$731M $167M $196M -$29M
Change in Inventories $56M -$384M -$389M $465M -$30M
Cash From Operations $966M $1.2B $2.3B $1.7B $1.3B
 
Capital Expenditures $635M $595M $780M $761M $758M
Cash Acquisitions -$38M -$242M -$3M -$3M -$167M
Cash From Investing -$739M -$547M -$1.1B -$664M -$721M
 
Dividends Paid (Ex Special Dividend) -- -- -$78M -- -$37M
Special Dividend Paid
Long-Term Debt Issued $1.1B $1.5B $960M $573M $1.1B
Long-Term Debt Repaid -$1.5B -$1.4B -$1.5B -$1.2B -$1.5B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $42M $239M $11M -- -$14M
Cash From Financing -$691M -$117M -$1.3B -$1.1B -$707M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$464M $578M -$118M -$97M -$125M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $331M $647M $1.5B $904M $545M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $135M $691M $288M $140M $102M
Depreciation & Amoritzation $118M $123M $131M $148M $152M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$156M -$470M -$41M -$123M -$217M
Change in Inventories $30M -$87M $51M $51M $28M
Cash From Operations $224M $358M $432M $275M $155M
 
Capital Expenditures $147M $131M $164M $145M $190M
Cash Acquisitions -$64M $20M $2M -$7M -$119M
Cash From Investing -$336M -$53M -$435M -$3M -$381M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $310M $393M $258M $198M $361M
Long-Term Debt Repaid -$496M -$386M -$255M -$386M -$397M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $16M $237M $7M -- -$2M
Cash From Financing -$263M $23M -$87M -$254M $18M
 
Beginning Cash (CF) $618M $508M $762M $537M $618M
Foreign Exchange Rate Adjustment $1M $6M $1M -$5M $7M
Additions / Reductions -$375M $328M -$90M $18M -$208M
Ending Cash (CF) $244M $842M $673M $550M $417M
 
Levered Free Cash Flow $77M $227M $268M $130M -$35M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Brown Forman Stock Go?
How High Will Brown Forman Stock Go?

On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock